NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

非口服營養的全球市場的規模、佔有率、趨勢分析:營養物的各類型 (碳水化合物、脂肪乳劑、單劑量氨基酸溶液,微量礦物質,維生素和礦物質)、各地區、各領域的未來預測

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements), By Region, And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 361259
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
非口服營養的全球市場的規模、佔有率、趨勢分析:營養物的各類型 (碳水化合物、脂肪乳劑、單劑量氨基酸溶液,微量礦物質,維生素和礦物質)、各地區、各領域的未來預測 Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements), By Region, And Segment Forecasts, 2019 - 2026
出版日期: 2019年03月22日內容資訊: 英文 100 Pages
簡介

全球非口服營養的市場規模,2024年預計達到73億美元。在各地區中美國視最大的市場,尤其是由於非口服營養也能使用於居家醫療,以心臟病患者為中心需求擴大。還有中國、印度等開發中國家市場也急速擴大。

本報告提供全球非口服營養市場相關分析,整體市場規模的變化、預測 (過去4年、今後8年份) ,及主要推動及阻礙市場要素,營養素的各類型、各地區的詳細趨勢,主要企業的簡介、市場佔有率等調查評估。

第1章 分析方法、範圍

第2章 摘要整理

第3章 非口服營養市場:變動要素、趨勢、範圍

  • 相關市場未來展望
    • 母體市場分析
    • 相關/附隨市場分析
  • 產品普及率、市場成長率預測:製圖
  • 用戶方面的見解分析
    • 消費行為分析
    • 市場影響要素 (影響者)
  • 管理體制
    • 醫療費償付制度
    • 產業標準與其遵守
  • 市場變動要素分析
    • 市場動態
      • 推動市場要素
      • 阻礙市場要素
      • 產業的相關課題
  • 非口服營養市場:分析工具
    • 波特的五力分析
    • PESTEL分析
    • 主要的資本交易/策略性聯合趨勢分析
    • 打入市場策略

第4章 非口服營養市場:各產品種類分析

  • 定義和範圍
  • 市場佔有率分析:各產品種類 (最新值、預測值)
  • 碳水化合物
    • 市場規模 (以金額為準,總計12年份)
  • 非口服脂肪乳劑
  • 單劑量氨基酸溶液
  • 微量礦物質
  • 維生素和礦物質

第5章 非口服營養市場:各地區的分析

  • 定義和範圍
  • 各地區市場現狀
  • 市場佔有率分析:各地區 (最新值)
  • 非口服營養市場:市場佔有率分析 (最新值、預測值)
  • 北美市場 (美國,加拿大)
    • 市場規模:各國 (以金額為準,總計12年份)
  • 歐洲市場 (英國,德國,法國,義大利,西班牙)
  • 亞太地區市場 (日本,中國,印度,泰國,韓國)
  • 南美市場 (巴西,墨西哥,阿根廷,哥倫比亞)
  • 中東、非洲市場 (南非,沙烏地阿拉伯,UAE)

第6章 企業簡介

  • B. Braun Melsungen AG
    • 企業概要
    • 財務成果
    • 產品比較分析
    • 策略性配合措施
  • Fresenius Kabi AG
  • Allergan Plc
  • Grifols, S.A.
  • Pfizer, Inc.(Hospira)
  • 大塚製藥工廠
  • Baxter International, Inc.
  • Sichuan Kelun Pharmaceutical Co., Ltd
  • Vifor Pharma
  • Aculife (Nirlife)

第7章 KOL (產業的意見領袖)的見解

第8章 建議

目錄
Product Code: 978-1-68038-867-1

The global parenteral nutrition market size is expected to reach USD 8.26 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing rate of natality and surging geriatric population is fueling the market growth.

As of 2014, the natality rate reported by the National Center for Health Statistics (NCHS) is 12.5 births per 1,000 populations in U.S. Furthermore, the percentage of lower weight infants was 8.0%, thereby boosting the demand for parenteral nutrition products in the country.

The realized natality is rising over the last decade and is anticipated to sustain growth over the forecast period. However, in 2011, a dip was witnessed in U.S. owing to alteration in fertility rate of the local female population. However, in the same year, hike in the number of births for foreign based immigrant citizens was also observed leading to an overall rise in birth rate.

Moreover, a large number of premature babies suffer from low weight as well as undeveloped immunity thus putting them at risk. Parenteral nutrition reduces the risk of infection and underdevelopment, thereby promoting its application.

As per the National Center for Healthcare Statistics, the premature birth rate of the U.S. is about 9.6% as of 2016, and the national authorities are working to reduce it to 8.1%.

In very low birth weight (VLBW) newborns, demand for parenteral nutrition is higher owing to low prospect of enteral nutrition. Hence, use of parenteral nutrition in premature infants results in improved intrauterine nutrient deposition, faster neurological development, and minimized risk of complications thus improving their chances for survival.

Further key findings from the study suggest:

  • Single dose amino acid solution segment dominated the market in 2018 owing to increasing use of amino acid solutions that possess fewer side effects thus enhancing patient benefits
  • North America led the market in terms of revenue and accounted for 41.73% of the overall share in 2018. Presence of high research expenditure by private entities and government agencies in the healthcare sector and collaborations among medical device industry, regulatory authorities, and universities are responsible for the market growth

Some of the companies present in the parenteral nutrition market are: B. Braun Melsungen AG; Baxter International, Inc.; Fresenius Kabi AG; Hospira, Inc.; Actavis, Inc.; Grifols International S.A.; Otsuka Pharmaceutical Factory, Inc.; and Sichuan Kelun Pharmaceutical Co. Ltd.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Nutrition Type
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1:
    • 1.10.2 Objective - 2:
    • 1.10.3 Objective - 3:
    • 1.10.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Parenteral Nutrition Market: Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 Regulatory Framework
    • 3.4.1 Reimbursement Framework
    • 3.4.2 Standards & Compliances
  • 3.5 Market Variable Analysis
    • 3.5.1 Market Driver Analysis
      • 3.5.1.1 Increasing Natality Rate
      • 3.5.1.2 Rising Number Of Premature Births
      • 3.5.1.3 Risk Of Malnutrition
      • 3.5.1.4 Rising Base Of Geriatric Population
      • 3.5.1.5 Increasing Incidence Of Cancer
    • 3.5.2 Market Restraint Analysis
      • 3.5.2.1 Increased Use Of Enteral Nutrition
      • 3.5.2.2 High Risk Of Infection
      • 3.5.2.3 Shortage Of Parenteral Nutrition Products
    • 3.5.3 Industry Challenges
  • 3.6 Parenteral Nutrition Market: Analysis Tools
    • 3.6.1 Porter's Five Forces Analysis
    • 3.6.2 Pestel Analysis
    • 3.6.3 Major Deals & Strategic Alliances Analysis
    • 3.6.4 Market Entry Strategies

Chapter 4 Parenteral Nutrition Market: Product Segment Analysis

  • 4.1 Parenteral Nutrition Market: Definition & Scope
  • 4.2 Parenteral Nutrition: Market Share Analysis, 2018 & 2026
  • 4.3 Carbohydrates
    • 4.3.1 Carbohydrates Market, 2015 - 2026 (USD Million)
  • 4.4 Parenteral Lipid Emulsion
    • 4.4.1 Parenteral Lipid Emulsion Market, 2015 - 2026 (USD Million)
  • 4.5 Single Dose Amino Acid Solution
    • 4.5.1 Single Dose Amino Acid Solution Market, 2015 - 2026 (USD Million)
  • 4.6 Trace Elements
    • 4.6.1 Trace Elements Market, 2015 - 2026 (USD Million)
  • 4.7 Vitamins & Minerals
    • 4.7.1 Vitamins & Minerals Market, 2015 - 2026 (USD Million)

Chapter 5 Parenteral Nutrition Market: Regional Analysis

  • 5.1 Parenteral Nutrition Market: Definition & Scope
  • 5.2 Regional Market Snapshot
  • 5.3 Regional Market Share, 2018
  • 5.4 Parenteral Nutrition Market: Market Share Analysis, 2018 & 2026
  • 5.5 North America
    • 5.5.1 North America Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.5.2 U.S.
      • 5.5.2.1 U.S. Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.5.3 Canada
      • 5.5.3.1 Canada Parenteral Nutrition Market, 2015 - 2026 (USD Million)
  • 5.6 Europe
    • 5.6.1 Europe Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.6.2 U.K.
      • 5.6.2.1 U.K. Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.6.3 Germany
      • 5.6.3.1 Germany Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.6.4 France
      • 5.6.4.1 France Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.6.5 Italy
      • 5.6.5.1 Italy Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.6.6 Spain
      • 5.6.6.1 Spain Parenteral Nutrition Market, 2015 - 2026 (USD Million)
  • 5.7 Asia Pacific
    • 5.7.1 Asia Pacific Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.7.2 Japan
      • 5.7.2.1 Japan Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.7.3 China
      • 5.7.3.1 China Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.7.4 India
      • 5.7.4.1 India Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.7.5 Thailand
      • 5.7.5.1 Thailand Parenteral Nutrition Market, 2015 - 2026 (USD Million)
    • 5.7.6 South Korea
      • 5.7.6.1 South Korea Parenteral nutrition market, 2015 - 2026 (USD Million)
  • 5.8 Latin America
    • 5.8.1 Latin America parenteral nutrition market, 2015 - 2026 (USD Million)
    • 5.8.2 Brazil
      • 5.8.2.1 Brazil parenteral nutrition market, 2015 - 2026 (USD Million)
    • 5.8.3 Mexico
      • 5.8.3.1 Mexico parenteral nutrition market, 2015 - 2026 (USD Million)
    • 5.8.4 Argentina
      • 5.8.4.1 Argentina parenteral nutrition market, 2015 - 2026 (USD Million)
    • 5.8.5 colombia
      • 5.8.5.1 Colombia parenteral nutrition market, 2015 - 2026 (USD Million)
  • 5.9 MEA
    • 5.9.1 MEA parenteral nutrition market, 2015 - 2026 (USD Million)
    • 5.9.2 South Africa
      • 5.9.2.1 South Africa parenteral nutrition market, 2015 - 2026 (USD Million)
    • 5.9.3 Saudi Arabia
      • 5.9.3.1 Saudi Arabia parenteral nutrition market, 2015 - 2026 (USD Million)
    • 5.9.4 UAE
      • 5.9.4.1 UAE parenteral nutrition market, 2015 - 2026 (USD Million)

Chapter 6 Company Profiles

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
      • 6.1.1.1 Company overview
      • 6.1.1.2 Financial performance
      • 6.1.1.3 Product benchmarking
      • 6.1.1.4 Strategic initiatives
    • 6.1.2 Fresenius Kabi AG
      • 6.1.2.1 Company overview
      • 6.1.2.2 Product benchmarking
      • 6.1.2.3 Strategic initiatives
    • 6.1.3 Allergan Plc
      • 6.1.3.1 Company overview
      • 6.1.3.2 Financial performance
      • 6.1.3.3 Service benchmarking
      • 6.1.3.4 Strategic initiatives
    • 6.1.4 Grifols, S.A.
      • 6.1.4.1 Company overview
      • 6.1.4.2 Financial Performance
      • 6.1.4.3 Product benchmarking
      • 6.1.4.4 Strategic initiatives
    • 6.1.5 Pfizer, Inc.(Hospira)
      • 6.1.5.1 Company overview
      • 6.1.5.2 Product benchmarking
      • 6.1.5.3 Strategic initiatives
    • 6.1.6 Otsuka Pharmaceutical Factory, Inc.
      • 6.1.6.1 Company overview
      • 6.1.6.2 Product benchmarking
      • 6.1.6.3 Strategic initiatives
    • 6.1.7 Baxter International, Inc.
      • 6.1.7.1 Company overview
      • 6.1.7.2 Financial performance
      • 6.1.7.3 Product benchmarking
      • 6.1.7.4 Strategic initiatives
    • 6.1.8 Sichuan Kelun Pharmaceutical Co., Ltd
      • 6.1.8.1 Company overview
      • 6.1.8.2 Product benchmarking
    • 6.1.9 Vifor Pharma
      • 6.1.9.1 Company overview
      • 6.1.9.2 Product benchmarking
      • 6.1.9.3 Strategic initiatives
    • 6.1.10 Aculife (Nirlife)
      • 6.1.10.1 Company overview
      • 6.1.10.2 Product benchmarking

Chapter 7 KOL Commentary

  • 7.1 Key Insights
  • 7.2 KOL Views

Chapter 8 Recommendations

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Global Parenteral Nutrition Market, by Region, 2015 - 2026 (USD Million)
  • Table 4 Global Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 5 North America Parenteral Nutrition Market, by Country, 2015 - 2026 (USD Million)
  • Table 6 North America Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 7 U.S. Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 8 Canada Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 9 Europe Parenteral Nutrition Market, by Country, 2015 - 2026 (USD Million)
  • Table 10 Europe Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 11 U.K. Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 12 Germany Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 13 Spain Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 14 Italy Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 15 France Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 16 RoE Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 17 Asia Pacific Parenteral Nutrition Market, by Country, 2015 - 2026 (USD Million)
  • Table 18 Asia Pacific Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 19 Japan Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 20 China Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 21 India Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 22 Thailand Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 23 South Korea Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 24 RoAPAC Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 25 Latin America Parenteral Nutrition Market, by Country, 2015 - 2026 (USD Million)
  • Table 26 Latin America Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 27 Brazil Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 28 Mexico Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 29 Argentina Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 30 Colombia Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 31 RoLA Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 32 MEA Parenteral Nutrition Market, by Country, 2015 - 2026 (USD Million)
  • Table 33 MEA Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 34 South Africa Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 35 Saudi Arabia Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 36 UAE Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)
  • Table 37 RoMEA Parenteral Nutrition Market, by Nutrient Type, 2015 - 2026 (USD Million)

List of Figures

  • Fig.1 Market research process
  • Fig.2 Information procurement
  • Fig.3 Primary research pattern
  • Fig.4 Market research approaches
  • Fig.5 Value-chain-based sizing & forecasting
  • Fig.6 QFD modeling for market share assessment
  • Fig.7 Market formulation & validation
  • Fig.8 Commodity Flow Analysis
  • Fig.9 Volume Price Analysis
  • Fig.10 Parenteral nutrition market snapshot (2018)
  • Fig.11 Parenteral nutrition market segmentation
  • Fig.12 Parenteral nutrition market: Strategy framework
  • Fig.13 Market trends and outlook
  • Fig.14 Parent market outlook
  • Fig.15 Related/ancillary market outlook
  • Fig.16 Penetration & growth prospect mapping
  • Fig.17 Market driver relevance analysis (Current & future impact)
  • Fig.18 Global geriatric population, 2014 - 2024 (Million)
  • Fig.19 Global geriatric population, 2014 - 2024 (Million)
  • Fig.20 Cancer (all types) incidences per 100,000 populations, 2012
  • Fig.21 Market restraint relevance analysis (Current & future impact)
  • Fig.22 Porter's five forces analysis
  • Fig.23 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig.24 Parenteral nutrition market service outlook: Segment dashboard
  • Fig.25 Parenteral nutrition market: Product movement analysis
  • Fig.26 Carbohydrates market, 2015 - 2026 (USD Million)
  • Fig.27 Parenteral lipid emulsion market, 2015 - 2026 (USD Million)
  • Fig.28 Single dose amino acid solution market, 2015 - 2026 (USD Million)
  • Fig.29 Trace elements market, 2015 - 2026 (USD Million)
  • Fig.30 Vitamins & minerals market, 2015 - 2026 (USD Million)
  • Fig.31 Regional market place: Key takeaways
  • Fig.32 Parenteral nutrition market: Definition & scope
  • Fig.33 Regional market snapshot (Figures in USD Million, 2018)
  • Fig.34 Regional market share, 2018 (USD Million)
  • Fig.35 Regional outlook, 2018 & 2026
  • Fig.36 North America market, 2015 - 2026 (USD Million)
  • Fig.37 U.S. market, 2015 - 2026 (USD Million)
  • Fig.38 Canada market, 2015 - 2026 (USD Million)
  • Fig.39 Europe market, 2015 - 2026 (USD Million)
  • Fig.40 U.K. market, 2015 - 2026 (USD Million)
  • Fig.41 Germany market, 2015 - 2026 (USD Million)
  • Fig.42 France market, 2015 - 2026 (USD Million)
  • Fig.43 Italy market, 2015 - 2026 (USD Million)
  • Fig.44 Spain market, 2015 - 2026 (USD Million)
  • Fig.45 Asia Pacific market, 2015 - 2026 (USD Million)
  • Fig.46 Japan market, 2015 - 2026 (USD Million)
  • Fig.47 China market, 2015 - 2026 (USD Million)
  • Fig.48 India market, 2015 - 2026 (USD Million)
  • Fig.49 Thailand market, 2015 - 2026 (USD Million)
  • Fig.50 South Korea market, 2015 - 2026 (USD Million)
  • Fig.51 Latin America market, 2015 - 2026 (USD Million)
  • Fig.52 Brazil market, 2015 - 2026 (USD Million)
  • Fig.53 Mexico market, 2015 - 2026 (USD Million)
  • Fig.54 Argentina market, 2015 - 2026 (USD Million)
  • Fig.55 Colombia market, 2015 - 2026 (USD Million)
  • Fig.56 MEA market, 2015 - 2026 (USD Million)
  • Fig.57 South Africa market, 2015 - 2026 (USD Million)
  • Fig.58 Saudi Arabia market, 2015 - 2026 (USD Million)
  • Fig.59 UAE market, 2015 - 2026 (USD Million)